Warning! Biden’s Pushing Paxlovid, the Pfizer Flop Drug
M Dowling – July 22, 2022 Upon launch, Pfizer said their new anti-viral drug Paxlovid cut hospitalization and death by 90%. An updated, more recent analysis from 1,153 patients (out of a possible 2,246 patients) showed a lackluster, non-significant 51% relative risk reduction. A sub-group analysis of 721 vaccinated adults with at least one risk […]Read More